20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 2, 2001, Pages 231-237

  McGiff, John C ^a   Quilley, John ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN; ENDOTHELIN; EPOXYICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; NITRIC OXIDE; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

AGE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; DIURESIS; ELECTROLYTE EXCRETION; HYPERTENSION; ION TRANSPORT; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SODIUM EXCRETION;

ANIMALS; BLOOD PRESSURE; CEREBROVASCULAR CIRCULATION; FATTY ACIDS, UNSATURATED; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; MUSCLE, SKELETAL; OXYGEN; RATS; RENAL CIRCULATION;

EID: 0035104516     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200103000-00012     Document Type: Article

References (50)

1. Angiotensin II releases 20-HETE from rat renal microvessels
2. 20-HETE and the kidney: Resolution of old problems and new beginnings
3. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys
4. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles
5. 2 receptor
6. Integrating multiple paracrine regulators of renal microvascular dynamics
7. Renal cytochrome P450 ω-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride
8. Functional response of the rat kidney to inhibition of nitric oxide synthesis: Role of cytochrome P450-derived arachidonate metabolites
9. B receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole
10. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses
11. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
12. Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness
13. Treatment with fin prevents the development of hypertension in spontaneously hypertensive rats
14. Fenofibrate lowers blood pressure in two genetic models of hypertension
15. 20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive rats
16. Localization of cytochrome p450 4A isoforms along the rat nephron
17. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb celts
18. + are age dependent
19. Kinetic profile of the rat CYP4A isoforms: Arachidonic acid metabolism and isoform-specific inhibitors
20. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats
21. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle
22. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport
23. Mechanism of regulation of Na+ transport by angiotensin II in primary renal cells
24. An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells
25. Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites
26. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries
27. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation
28. Production of 20-HETE and its role in autoregulation of cerebral blood flow
29. 20-HETE agonists and antagonists in the renal circulation
30. Regulation of vascular tone. Role of 20-HETE in the modulation of myogenic reactivity
31. Identification of a putative microvascular oxygen sensor
32. Role of cytochrome P-450 4A in oxygen sensing and NO production in rat cremaster resistance arteries
33. Contribution of cytochrome p-450 ω-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension
34. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo
35. Fluorescent HPLC assay for 20-HETE and other P450 metabolites of arachidonic acid
36. Angiotensin II-induced hypertension. Contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites
37. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension
38. Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice
39. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors
40. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet
41. Actions of epoxygenase metabolites on the preglomerular vasculature
42. 5,6 Epoxyeicosatrienoic acid, a novel arachidonate metabolite
43. Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells
44. The kidney cytochrome P450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading
45. Is EDHF an epoxyeicosatrienoic acid?
46. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney
47. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor
48. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation
49. Epoxyeicosatrienoic acid mediated renal vasodilatation to arachidonic acid is enhanced in the SHR
50. Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate monooxygenase